BiotechTube

Gadoxetate disodium (Eovist/Primovist, BAY86-4873)

Phase 3Terminated
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Magnetic Resonance Imaging

Conditions

Magnetic Resonance Imaging

Trial Timeline

Feb 1, 2015 → Aug 1, 2015

NCT ID
NCT02084628

About Gadoxetate disodium (Eovist/Primovist, BAY86-4873)

Gadoxetate disodium (Eovist/Primovist, BAY86-4873) is a phase 3 stage product being developed by Bayer for Magnetic Resonance Imaging. The current trial status is terminated. This product is registered under clinical trial identifier NCT02084628. Target conditions include Magnetic Resonance Imaging.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02084628Phase 3Terminated

Competing Products

20 competing products in Magnetic Resonance Imaging

See all competitors
ProductCompanyStageHype Score
HRS-9231 + GadobutrolJiangsu Hengrui MedicinePhase 2
52
D1000078 + D1000082 + D1000083 + D1000085AstraZenecaPhase 1
33
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882)BayerPhase 3
74
Gadoquatrane (BAY1747846)BayerPhase 3
74
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)BayerPhase 2
49
GBCAsBayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875)BayerPhase 3
74
BAY1747846BayerPhase 1
30
Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerApproved
82
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadopentetate dimeglumine (Magnevist, BAY86-6661)BayerPhase 3
74
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadavist, Gadovist, BAY86-4875)BayerPhase 1
30
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadavist, BAY86-4875)BayerPhase 1
30
BAY1747846 + Matching placeboBayerPhase 1
30
Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placeboBayerPhase 1
30
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82